AbbVie (ABBV), a large drug maker, is jumping 8% after the company provided significantly higher-than-expected 2025 earnings ...
Psoriasis, a painful and uncomfortable inflammatory skin condition that affects millions worldwide, flares up from the ...
AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq ...